baber/WOPTO huggingface dataset:
Patent CA-2520935-C (CA)
Title: Pancake die
Inventor: GALLINA DAVID N
IPC: A21C11/00
Filed: 2004-03-22
Granted: 2011-03-15
Abstract: An improved pancake die is provided for use in a pancake production system for producing pancakes having a highly uniform weight but exhibiting a substantially randorn peripheral shape reflective of a desirable home made appearance. The pancake die comprises a cavity of selected geometric shape formed in a reciprocal die plate adapted for movement between a first position underlying a batter reservoir for filling the die cavity with batter, and a second position underlying a discharge plunger for pushing the formed pancake from the die cavity onto a discharge conveyor for further processing. The die cavity is subdivided into an upper zone having the selected geometric shape, and an enlarged undercut lower zone separated therefrom by a substantially radially outwardly extending step. With this configuration, the periphery of each formed pancake distorts in a substantially randorn manner upon engagement by the discharge plunger, to provide a desirable homemade product appearance.
Patent CA-2523131-C (CA)
Title: Inflatable intervertebral disc replacement prosthesis
Inventor: SUDDABY LOUBERT
IPC: A61F2/30
Filed: 2004-04-22
Granted: 2008-10-07
Abstract: An intervertebral disc replacement prosthesis which can be implanted in a collapsed state, then expanded within the disc space such that minimally invasive surgical techniques may be employed for its insertion. With this prosthesis, ligaments can be restored to proper tension, facet joints can be unloaded posteriorly to inhibit degenerative changes, and functional mobility of the intervertebral segment can be restored.
Patent CA-2525056-C (CA)
Inventor: XUE LIJUE
IPC: G02F1/1524
Filed: 2005-10-31
Granted: 2012-12-04
Abstract: An electrochromic material having improved durability and more pleasing color characteristics is composed of a single-phase compound of formula W1-x Ta x O3- x/2, x having a value in a range of from about 0.15 to about 0.5. Thin films of the electrochromic material can be manufactured by pulse laser deposition (PLD). Thin films of the electrochromic material are useful in the fabrication of electrochromic devices, such as "smart" windows, mirrors, information displays and variable emittance surfaces.
Patent CA-2529414-C (CA)
Inventor: WENTLING ANGELA
IPC: A61M25/00
Filed: 2004-08-06
Granted: 2011-11-15
Abstract: A continuous flow dialysis catheter (10) is disclosed. The catheter (10) includes a proximal portion having first proximal end (16), a first distal end (20), an intake lumen (12) and a return lumen (14). Each of the intake (12) and return lumens (14) extends between the first proximal end (16) and the first distal end (20). The catheter (10) also includes a connector portion fixedly connected to the first distal portion, wherein the return lumen (14) terminates at the connector portion. The catheter (10) also includes a distal portion having a second proximal end (18), a second distal end (22), and a distal lumen extending between the second proximal end (18) and the second distal end (22). The second distal end (22) is fixedly connected to the connector portion such that the distal lumen and the intake lumen (12) are in fluid communication with each other.
Patent CA-2529682-C (CA)
Title: Screen device
Inventor: MORIYA MASATO
IPC: E06B9/52
Filed: 2004-06-29
Granted: 2008-11-25
Abstract: The present invention provides a screen device including a screen guide that has a simple structure, stably operates, and, in a guided-out state, can be formed in a straight rail-like shape. A screen guide 12 of the screen device includes a large number of guide pieces 14, each formed in an approximately U-shape by a bottom 14a and standing walls 14b respectively extending along the end of a screen 4 and the external side surfaces of the screen, and having a structure in which passage holes 14c are formed along the tops of the standing walls, two strings of wire members 16 are exerted through the respective passage holes, and, when the screen guide is guided out along the end of the screen, the serial contact surfaces of the adjacent guide pieces 14 abut against each other.
Patent CA-2530583-C (CA)
Title: The polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
Inventor: LOCKE KENNETH WALTER
IPC: C07C381/00
Filed: 2004-06-24
Granted: 2010-08-10
Abstract: A pharmaceutical composition, comprising: a compound of formula (1) in polymorphic crystalline Form A: (1) together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic Form A (see, e.g., Fig 6) substantially free of other polymorphic forms.
Patent CA-2531608-C (CA)
Title: Surface-modified pyrogenically prepared titanium dioxides
Inventor: MEYER JUERGEN
IPC: A61Q17/04
Filed: 2005-12-22
Granted: 2012-07-17
Abstract: Surface-modified, pyrogenically prepared titanium dioxides coated with silicon dioxide are prepared by spraying the pyrogenically prepared titanium dioxides coated with silicon dioxide with a surface-modifying agent and then tempering them. They can be used in sun protection formulations.
Patent CA-2536108-C (CA)
Inventor: FINK JOHN K
IPC: G01N33/53
Filed: 2004-08-19
Granted: 2012-10-16
Abstract: The present invention relates to the NIPA-1 proteins and nucleic acids encoding the NfPA-I proteins. The present invention further provides assays for the detection of NIPA-I polymorphisms and mutations associated with disease states, as well as methods of screening for ligands and modulators of NIPA-1 proteins.
Patent CA-2550562-C (CA)
Inventor: WADDOUPS MALCOLM
IPC: C10M107/08
Filed: 2006-06-14
Granted: 2011-07-05
Abstract: Une nouvelle huile à faible émission de fumée pour moteur deux temps comprend du polyisobutylène hautement réactif (PIB-HR), un ensemble d'additifs pour solvant, et exhibe une viscocité cinématique d'au moins 6,5 mm2/s à 100 degrés et un indice de fumée JASO M342 d'au moins 85. Cette nouvelle huile pour moteur deux temps est produite à partir d'un matériau de départ qui procure une nouvelle efficacité comparativement au polyisobutylene (PIB), qui a habituellement été inclus dans les huiles classiques pour moteur deux temps.
Patent CA-2557272-C (CA)
Title: Heterocyclic derivatives
Inventor: GIELEN-HAERTWIG HEIKE
IPC: C07D413/14
Filed: 2005-02-15
Granted: 2012-09-11
Abstract: The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
Patent CA-2558496-C (CA)
Inventor: BLUM STEPHAN RUDIGER
IPC: H01M8/10
Filed: 2005-03-01
Granted: 2014-01-14
Abstract: A fuel cell comprising a reaction chamber; a plurality of capillary tubes configured to permit a fuel component to flow there through, the capillary tubes being arranged in bundles in adjacent segments within the reaction chamber; a plurality of electrodes, at least one of the plurality of electrodes passing through each of the plurality of capillary tubes, being against each of the plurality of capillary tubes, or passing through and being against each of the plurality of capillary tubes; and a plurality of counter-electrodes. Each electrode extends beyond ends of its respective capillary tubes, and electrodes associated with capillary tubes of a segment are electrically connected to one another at each end at substantially the same electrical potential. Each segment ha a wall section to which is attached at least one of the counter-electrodes or wherein the wall section at least partially forms at least one of the counter-electrodes.
Patent CA-2559947-C (CA)
Title: Environmentally pollution-free anti-corrosion pigment composition
Inventor: MATSUDA TAKASHI
IPC: C09C1/02
Filed: 2005-03-18
Granted: 2012-05-22
Abstract: The present invention provides an environmentally pollution-free, anti-corrosive pigment composition which is free of any heavy metal such as lead and/or chromium, which is free of zinc and/or water-soluble ions and which is excellent in the anti-corrosive effect. The anti-corrosive pigment composition comprises condensed calcium phosphate prepared by firing a mixture which comprises a calcium-containing component and a phosphorus-containing component and in which the molar ratio (Ca/P = m) of calcium to phosphorus present in these components falls within the following range: 0.50 < m < 1.00, at a temperature ranging from 180 to 350°C.
Patent CA-2564819-C (CA)
Inventor: KOSMYNA MICHAEL J
IPC: B05B7/24
Filed: 2005-05-27
Granted: 2013-03-12
Abstract: An adapter assembly for connecting a fluid supply assembly to a fluid applicator. The adapter assembly includes an outer lid (508) and a disposable inner lid (575) for the fluid supply assembly and an adapter (510). The adapter assembly provides a connection between the fluid supply assembly and the fluid applicator that can be engaged quickly, easily, and securely, and which has a strong tight seal around the connection.
Patent CA-2568166-C (CA)
Inventor: GUIOT SERGE R
IPC: C02F1/72
Filed: 2005-05-25
Granted: 2012-08-07
Abstract: The invention disclosure is a method of bioremediation of wastewater, particularly groundwater, by utilizing coupled anaerobic and aerobic biological treatment, more specifically, methanogenic (strictly anaerobic) and methanotrophic (strictly aerobic) microbial populations, in combination with a supply of in-situ generated water-dissolved oxygen and hydrogen. Water electrolysis is used to produce water-dissolved oxygen and hydrogen. The immediate advantage of using H2 from the electrolysis, is to provide electron donors to methanogens to reductively dechlorinate the chloroaliphatics, and to reduce the water carbonates and generate methane which is used as energy and carbon source for the methanotrophic bacteria. Oxygen is used as electron acceptor by the aerobic bacteria, including the methanotrophs. The addition of an organic carbon source can be minimized or even eliminated, so as to diminish the competition between methanotrophic bacteria and heterotrophic bacteria for oxygen.
Patent CA-2568952-C (CA)
Inventor: CHO HO SUNG
IPC: G01N33/53
Filed: 2005-06-17
Granted: 2019-05-21
Abstract: Novel antigen-binding polypeptides (ABP) and uses thereof are provided.
Patent CA-2581538-C (CA)
Title: Revetement reflechissant blanc pour membrane en bitume modifiee
Inventor: KHAN AMIR
IPC: C08K3/18
Filed: 2005-05-16
Granted: 2013-10-08
Abstract: L'invention concerne une composition de revêtement utile pour des produits de matériaux de construction, notamment pour des surfaces de toiture. La composition de revêtement assure une protection extérieure durable pour les surfaces sur lesquelles elle est appliquée et elle présente des propriétés réfléchissantes. La composition de revêtement comprend un mélange d'un liant polymère, d'un support polymère et d'un pigment. Le pigment est présent dans la composition de revêtement en une quantité qui permet d'obtenir un revêtement présentant un taux de rendement énergétique initial supérieur ou égal à 0,65 pour un toit à faible pente, ou un taux de rendement énergétique initial supérieur ou égal à 0,25 pour un toit à forte pente.
Patent CA-2583970-C (CA)
Title: Pipe coupling and male coupling member
Inventor: MATSUMOTO KOJI
IPC: F17C13/00
Filed: 2005-10-12
Granted: 2010-02-02
Abstract: A male coupling member is provided that is selectively couplable to a first female coupling member (for 25 MPa, for example) and a second female coupling member (for 90 MPa), which handle different fluid pressures. When the male coupling member is coupled to the first female coupling member, a second O-ring that is provided for the second female coupling member is prevented from being displaced by the fluid supplied from the first female coupling member. A through-hole (70) is provided therein with an O-ring retaining member (82) that is displaceable between an advance position (Fig. 3) where the O-ring retaining member is positioned radially inside the second O-ring (78) to prevent the second O-ring (78) from being displaced by the fluid flowing from the first female coupling member (20') through the through-hole when the male coupling member is coupled to the first female coupling member (20'), and a retract position (Fig. 1) where when the male coupling member is coupled to the second female coupling member (20), the O-ring retaining member is displaced backward by the forward end of a valving element (44) of the second female coupling member, thereby allowing the outer peripheral surface of the forward end of the valving element to hermetically engage the second O-ring.
Patent CA-2586624-C (CA)
Title: Crosslinked polymeric material with enhanced strength and process for manufacturing
Inventor: SCHROEDER DAVID W
IPC: B29C48/12
Filed: 2005-10-06
Granted: 2014-01-14
Abstract: A radiation crosslinked (50 kGy), pressure-treated UHMWPE material has been developed by applying compressive force on a crosslinked polymer in a direction orthogonal to an axial direction. The deformed material is then cooled while held in a deformed state. The resulting material is anisotropic, with enhanced strength oriented along the axial direction. The directionally engineered material is oxidatively stable even after four weeks of accelerated aging in a pressure vessel containing five atmospheres of oxygen (ASTM F2003).  Because of its oxidative stability, the deformation processed material is a suitable candidate for air-permeable packaging and gas sterilization, which has thus far been reserved for remelted highly crosslinked UHMWPEs.
Patent CA-2589615-C (CA)
Title: Multibar apparatus and method for electrically stimulating a carcass
Inventor: LACY KELLY
IPC: A22C9/00
Filed: 2007-05-22
Granted: 2012-08-21
Abstract: The present invention is directed to a method and apparatus for the differential and purposeful stimulation of an animal carcass, i.e. substantially an entire animal carcass, without the purge problems typically found in the anterior and posterior portions of the animal carcass. In one embodiment, the method includes electrically stimulating at least a first section of the animal carcass to a first degree and electrically stimulating at least a second section of the animal carcass to a second degree less than the first degree. In one embodiment, the muscles of the midsection are electrically stimulated to a first degree and the muscles of the anterior and posterior end sections are electrically stimulated to a second degree less than the first degree. An apparatus for carrying out the methods of the present invention are further provided.
Patent CA-2591972-C (CA)
Title: Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
Inventor: BENKE KLAUS
IPC: A61K9/20
Filed: 2005-12-13
Granted: 2012-06-19
Abstract: The present invention relates to solid, modified-release pharmaceutical dosage forms which can be administered orally and comprise 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide, and process for their production, their use as medicaments, their use for the prophylaxis, secondary prophylaxis and/or treatment of disorders, and their use for producing a medicament for the prophylaxis, secondary prophylaxis and/or treatment of disorders.
Patent CA-2592555-C (CA)
Title: Oligonucleotidic sequences for the amplification of hiv-2 and siv-type retrovirus genome, and their applications for the in vitro diagnosis of infections due to these virus
Inventor: COURGNAUD VALERIE
IPC: C12P19/34
Filed: 1990-06-05
Granted: 2010-01-05
Abstract: The invention relates to oligonucleotide sequences (or initiators) derived from the HIV-2 ROD virus genome and from that of the SIV-mac 142 virus, as well as their use in an in vitro method for the diagnosis of the infection of an individual by a HIV-2 type virus.
Patent CA-2596714-C (CA)
Title: Method for treating gefitinib resistant cancer
Inventor: HABER DANIEL
IPC: A61K31/00
Filed: 2006-02-02
Granted: 2014-06-17
Abstract: The present invention is directed to methods for the treatment of gefitinib and/or erlotinib resistant cancer. An individual with cancer is monitored for cancer progression following treatment with gefitinib and/or erlotinib. Progression of the cancer is indicative that the cancer is resistant to gefitinib and/ or erlotinib. Once progression of cancer is noted, the subject is administered a pharmaceutical composition comprising an irreversible epidermal growth factor receptor (EGFR) inhibitor. In preferred embodiments, the irreversible EGFR inhibitor is EKB-569, HKI-272 and HKI-357.
Patent CA-2599754-C (CA)
Inventor: CAO MING YU
IPC: A61K39/00
Filed: 2006-03-08
Granted: 2012-06-19
Abstract: The use of interleukin 17E to inhibit tumour growth in a subject is provided.  The interleukin 17E can be provided to the subject exogenously, as an interleukin 17E polypeptide or a polynucleotide encoding an interleukin 17E  polypeptide, or it can be provided by stimulating production of endogenous interleukin 17E. Also provided is the use of interleukin 17E in combination with one or more anti-cancer therapeutics for inhibiting tumour growth in a subject. Anti-cancer therapeutics include, for example, standard chemotherapeutic drugs, immunotherapeutics, radiation, gene therapy, hormone manipulation and antisense therapy.
Patent CA-2602283-C (CA)
Inventor: HOTANI SANAE
IPC: H03M13/35
Filed: 1999-05-27
Granted: 2009-09-01
Abstract: A multi-stage interleaving device comprises: N units of processing parts arranged in tiers. Each processing part comprises an operating memory providing a matrix of storage areas, input terminals receiving bit streams, a data writer writing the bit stream in the storage areas, starting from a top row from left to right. The data writer writes another bit stream to fill unfilled storage areas, starting from a left most column from top to bottom. A data reader is configured to read the bit streams in the matrix, starting from the left most column from top to bottom to output a third bit stream in which the bit streams are scattered at intervals. An output terminal is configured to output the third bit stream. A plurality of connections input and output the bit streams with the processing parts. N+1 lines of input connections provide two streams of input bits to the input terminals at the bottom tier. N-1 lines of output connections provide the third stream of bits from the output terminal to one of the input terminals.
Patent CA-2606428-C (CA)
Inventor: TURNER WILLIAM E
IPC: E21B7/06
Filed: 2006-04-26
Granted: 2015-07-14
Abstract: A system for rotating and guiding a drill bit (13) in an underground bore includes a drilling motor (25) and a drive shaft (31) . The system further includes a guidance module having an actuating arm (112) movable between an extended position wherein the actuating arm can contact a surface of the bore and thereby exert a force on the housing of the guidance module, and a retracted position. Furthermore the guidance module may comprise a hydraulic system with a pump (114) and a valve (120) . Also a second motor can be used.
Patent CA-2611818-C (CA)
Inventor: NEILL BRIAN
IPC: H04L9/00
Filed: 2006-06-12
Granted: 2015-12-29
Abstract: A system and method for remote device registration, to monitor and meter the injection of keying or other confidential information onto a device, is provided. A producer who utilizes one or more separate manufacturers, operates a remote module that communicates over forward and backward channels with a local module at the manufacturer. Encrypted data transmissions are sent by producer to the manufacturer and are decrypted to obtain sensitive data used in the devices. As data transmissions are decrypted, credits from a credit pool are depleted and can be replenished by the producer through credit instructions. As distribution images are decrypted, usage records are created and eventually concatenated, and sent as usage reports back to the producer, to enable the producer to monitor and meter production at the manufacturer. In an alternative arrangement overproduction may be inhibited by introducing a separation of duties within a manufacturing process. Typically a producer will contract out the various stages of manufacturing to multiple contractors. In general, separation of duties involves purposefully separating manufacturing stages, for silicon chips or other devices, so that the end product must have been ~touched~, by each subcontractor, in order for the end product to be fully functional.
Patent CA-2617021-C (CA)
Inventor: GOULET MICHEL
IPC: B32B21/02
Filed: 2008-01-07
Granted: 2010-11-23
Abstract: A building panel comprising a fiberboard panel providing the structural integrity of the building panel. An insulation layer is laminated to the fiberboard panel, the insulation layer providing a required thermal value to the building panel. A functional layer forms an air barrier, a water barrier and/or a vapor barrier of the building panel. The functional layer is secured to the fiberboard panel on the opposite side of the insulation layer.
Patent CA-2625797-C (CA)
Inventor: BERNUS CHRISTOPHE
IPC: B29C73/32
Filed: 2006-09-27
Granted: 2014-04-15
Abstract: A composite structure consists of two external skins (2, 3) and of an internal core (1) between them, wherein a portion (6) of one of the external skins (2) has to be replaced, with pressure from a counter-form (8) and suction. The repair is accomplished by piercing a vent hole (14) in the opposite external skin (3) in order to discharge the air in the cells of the core (1), which improves adhesive bonding of the new portion (6) on the core (1).
Patent CA-2627013-C (CA)
Title: Selection de donneurs de transfusion genotypes par epreuve de compatibilite croisee avec des receveurs genotypes
Inventor: ZHANG YI
IPC: G06F19/00
Filed: 2006-10-23
Granted: 2017-10-03
Abstract: L'invention porte sur des procédés qui permettent d'établir la compatibilité entre deux types sanguins sur la base d'une épreuve de compatibilité croisée (conformément à une règle de stringence désignée) entre les génotypes de groupe sanguin mineurs du receveur et des donneurs potentiels. Pour déterminer la compatibilité, on met en correspondance les génotypes de groupe sanguin avec les phénotypes correspondants en fonction des états d'expression associés à un ensemble d'halotypes sous-jacents, et on établit la compatibilité en établissant la compatibilité des types sanguins construits comme une combinaison de phénotypes constituants. Les chaînes de bits sont mises en correspondance, de préférence au moyen d'une expression algorithmique. Lorsqu'il y a ambiguïté dans la mise en correspondance des génotypes et des haplotypes, on peut réduire l'ambiguïté sur la base de la fréquence d'occurrence des haplotypes dans la population échantillon, ou la résoudre par le phasage des gamètes. Il est particulièrement souhaitable de procéder à la réduction ou à la résolution de l'ambiguïté lorsque les mésappariements dans les antigènes exprimés par les halotypes constituants possèdent une plus grande importance clinique.